Banner Life Sciences, LLC Sustainability Profile
Banner Life Sciences, LLC, headquartered in the United States, is a prominent player in the biopharmaceutical industry, specialising in the development and commercialisation of innovative therapies. Founded in 2013, the company has rapidly established itself as a leader in oncology and rare diseases, focusing on delivering unique solutions that address unmet medical needs. With a commitment to scientific excellence, Banner Life Sciences offers a range of products and services that leverage cutting-edge research and technology. Their portfolio includes advanced therapeutics that stand out for their efficacy and safety profiles. The company has achieved significant milestones, including strategic partnerships and successful product launches, solidifying its market position as a trusted provider in the healthcare sector.
DitchCarbon Score
How does Banner Life Sciences, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Banner Life Sciences, LLC's score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Banner Life Sciences, LLC's reported carbon emissions
Banner Life Sciences, LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of reported figures. The company is a current subsidiary of Cycle Pharmaceuticals Ltd, which may influence its climate commitments and emissions reporting. As of now, there are no documented reduction targets or climate pledges from Banner Life Sciences, LLC. The absence of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of developing its climate strategy or reporting framework. Given the lack of direct emissions data, it is essential to consider the broader industry context. Many companies in the life sciences sector are increasingly focusing on sustainability and carbon reduction, often setting ambitious targets aligned with global climate agreements. However, without specific commitments or data from Banner Life Sciences, it is challenging to assess their current position in this regard. In summary, while Banner Life Sciences, LLC does not currently report any carbon emissions or reduction targets, its affiliation with Cycle Pharmaceuticals Ltd may provide a framework for future climate initiatives and commitments.
How Carbon Intensive is Banner Life Sciences, LLC's Industry?
How Carbon Intensive is Banner Life Sciences, LLC's Location?
Banner Life Sciences, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Banner Life Sciences, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
